(Q37977360)

26 August 2017

1 reference

title

Angiotensin converting enzyme inhibitors and moderate hypertension (English)

1 reference

26 August 2017

main subject

arterial hypertension

0 references

author name string

McAreavey D

series ordinal

1

1 reference

26 August 2017

Robertson JI

series ordinal

2

1 reference

26 August 2017

publication date

1 September 1990

1 reference

26 August 2017

1 reference

26 August 2017

volume

40

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

326-345

1 reference

Splint renal function after captopril in unilateral renal artery stenosis

26 August 2017

cites work

1 reference

12 December 2020

Brain angiotensin: on the way to becoming a well-studied neuropeptide system

1 reference

12 December 2020

Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans

1 reference

12 December 2020

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

A study of the renin inhibitor H142 in man

1 reference

12 December 2020

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom

1 reference

12 December 2020

Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function

1 reference

12 December 2020

Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.

1 reference

12 December 2020

Thiazide-induced disturbances in carbohydrate, lipid, and potassium metabolism

1 reference

12 December 2020

Cough associated with captopril and enalapril

1 reference

12 December 2020

Antihypertensive effect of enalapril as first-step treatment of mild and moderate uncomplicated essential hypertension. Evaluation by two methods of blood pressure measurement

1 reference

12 December 2020

Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor.

1 reference

12 December 2020

Biochemistry and kinetics of the renin-angiotensin system

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: past, present, and bright future

1 reference

12 December 2020

Comparison of nifedipine and captopril as third-line agents in hypertensive patients uncontrolled with beta-blocker and diuretic therapy

1 reference

12 December 2020

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

1 reference

12 December 2020

Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients

1 reference

12 December 2020

Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension

1 reference

12 December 2020

The safety and tolerability of lisinopril in clinical trials

1 reference

12 December 2020

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

1 reference

12 December 2020

Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors in the elderly

1 reference

12 December 2020

Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.

1 reference

12 December 2020

Renin-angiotensin system: biochemistry and mechanisms of action

1 reference

12 December 2020

Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis

1 reference

12 December 2020

Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition

1 reference

12 December 2020

Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol

1 reference

12 December 2020

Angiotensin-converting enzyme and its clinical significance--a review

1 reference

12 December 2020

Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension.

1 reference

12 December 2020

Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination

1 reference

12 December 2020

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

1 reference

12 December 2020

Enalapril in essential hypertension

1 reference

12 December 2020

The effects of antihypertensive therapy on the quality of life

1 reference

12 December 2020

Actions of angiotensin II on the brain: mechanisms and physiologic role

1 reference

12 December 2020

Captopril and hydrochlorothiazide in the fixed combination multicenter trial

1 reference

12 December 2020

Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension

1 reference

12 December 2020

Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients

1 reference

12 December 2020

Implications of local angiotensin production in cardiovascular physiology and pharmacology

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition: renal aspect

1 reference

12 December 2020

Renal and systemic effects of enalapril in chronic one-kidney hypertension.

1 reference

12 December 2020

Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril

1 reference

12 December 2020

The site of angiotensin production

1 reference

12 December 2020

Guillain-Barré neuropathy during treatment with captopril

1 reference

12 December 2020

1 reference

12 December 2020

Do elderly patients with an excessive fall in blood pressure on standing have evidence of autonomic failure?

1 reference

12 December 2020

Atrial natriuretic peptides and renin release

1 reference

12 December 2020

Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice

1 reference

12 December 2020

Treatment of hypertension in the over-60s

1 reference

12 December 2020

A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide, and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension

1 reference

12 December 2020

Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats

1 reference

12 December 2020

1 reference

12 December 2020

Adrenal renin: a possible regulator of aldosterone production

1 reference

12 December 2020

Captopril: reversible renal failure with severe hyperkalaemia

1 reference

12 December 2020

Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: Medicinal chemistry and biological actions

1 reference

12 December 2020

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic

1 reference

12 December 2020

Captopril and nifedipine in combination for moderate to severe essential hypertension.

1 reference

12 December 2020

Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography

1 reference

12 December 2020

Short- and long-term effects of ramipril in hypertension.

1 reference

12 December 2020

Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril

1 reference

12 December 2020

Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril

1 reference

12 December 2020

Treating mild hypertension. Report of the British Hypertension Society working party

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

A new class of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

1 reference

12 December 2020

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Overall tolerance and safety of enalapril

1 reference

12 December 2020

Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney

1 reference

12 December 2020

Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.

1 reference

12 December 2020

Lisinopril: dose-peak effect relationship in essential hypertension

1 reference

12 December 2020

Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report

1 reference

12 December 2020

Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.

1 reference

12 December 2020

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Increased intralymphocytic sodium content in essential hypertension: an index of impaired Na+ cellular metabolism

1 reference

12 December 2020

A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo

1 reference

12 December 2020

Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension

1 reference

12 December 2020

Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria

1 reference

12 December 2020

Angiotensin receptors

1 reference

12 December 2020

Reversal of renal cortical actions of angiotensin II by verapamil and manganese

1 reference

12 December 2020

Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Captopril in heart failure. A double blind controlled trial

1 reference

12 December 2020

Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension

1 reference

12 December 2020

Efferent pathways of the cardiovascular response to vertebral artery infusions of angiotensin in the dog

1 reference

12 December 2020

Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension

1 reference

12 December 2020

The renin-angiotensin system and body function

1 reference

12 December 2020

1 reference

12 December 2020

A slowly developing pressor response to small concentrations of angiotensin. Its bearing on the pathogenesis of chronic renal hypertension

1 reference

12 December 2020

Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension

1 reference

12 December 2020

Intrarenal and intracellular distribution of renin and angiotensin

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans.

1 reference

12 December 2020

The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin--angiotensin--aldosterone system

1 reference

12 December 2020

The assay of renin in single glomeruli and the appearance of the juxtaglomerular apparatus in the rabbit following renal artery constriction

1 reference

12 December 2020

Hypertension and its treatment in the elderly

1 reference

12 December 2020

Symposium on angiotensin-converting enzyme inhibition: a developing concept

1 reference

12 December 2020

THE ASSAY OF RENIN IN SINGLE GLOMERULI IN THE NORMAL RABBIT AND THE APPEARANCE OF THE JUXTAGLOMERULAR APPARATUS

1 reference

12 December 2020

Review of the Overall Experience of Captopril in Hypertension

1 reference

12 December 2020

The large studies in hypertension: what have they shown?

1 reference

12 December 2020

The pharmacologic alteration of renin release.

1 reference

12 December 2020

Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway

1 reference

12 December 2020

Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome

1 reference

12 December 2020

Long-term effects of captopril and atenolol in essential hypertension

1 reference

12 December 2020

Comparative Antihypertensive Effects of Enalapril Maleate and Hydrochlorothiazide, Alone and in Combination

1 reference

12 December 2020

Enalapril in moderate to severe hypertension: a comparison with atenolol

1 reference

12 December 2020

The effect of diuretics on lymphocyte magnesium and potassium

1 reference

12 December 2020

Changes in blood pressure and body fluid volumes during diuretic therapy in patients with essential hypertension who receive enalapril

1 reference

12 December 2020

ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?

1 reference

12 December 2020

1 reference

12 December 2020

Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat

1 reference

12 December 2020

Metabolic and blood pressure effects of angiotensin converting enzyme inhibitors in mild-to-moderate American hypertensives

1 reference

12 December 2020

Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects

1 reference

12 December 2020

Clinical experience with captopril in the treatment of severe drug-resistant hypertension

1 reference

12 December 2020

Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.

1 reference

12 December 2020

Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patients

1 reference

12 December 2020

Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension

1 reference

12 December 2020

Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect

1 reference

12 December 2020

Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment

1 reference

12 December 2020

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

1 reference

12 December 2020

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo

1 reference

12 December 2020

Enalapril Worldwide Experience

1 reference

12 December 2020

A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension

1 reference

12 December 2020

Control of glomerular filtration rate by renin-angiotensin system

1 reference

12 December 2020

Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group

1 reference

12 December 2020

Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects

1 reference

12 December 2020

Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril

1 reference

12 December 2020

Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition and prostaglandins

1 reference

12 December 2020

Low-dose captopril in mild to moderate geriatric hypertension

1 reference

12 December 2020

The antihypertensive effect of lisinopril compared to atenolol in patients with mild to moderate hypertension

1 reference

12 December 2020

Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring

1 reference

12 December 2020

Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers

1 reference

12 December 2020

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial

1 reference

12 December 2020

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

The tubular effects of angiotensin II.

1 reference

12 December 2020

The effect of perindopril on blood pressure in humans on different sodium intakes

1 reference

12 December 2020

A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension

1 reference

12 December 2020

A need for new converting enzyme inhibitors?

1 reference

12 December 2020

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

1 reference

12 December 2020

Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics.

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in hypertension.

1 reference

12 December 2020

New evidence for brain angiotensin and for its role in hypertension

1 reference

12 December 2020

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

12 December 2020

Post marketing surveillance of captopril (for hypertension): a preliminary report

1 reference

12 December 2020

The response of blood pressure to infusion of angiotensin II: relation to plasma concentrations of renin and angiotensin II.

1 reference

12 December 2020

Severe hypotension after first dose of enalapril in heart failure

1 reference

12 December 2020

Tissue renin-angiotensin system: physiologic and pharmacologic implications. Introduction

1 reference

12 December 2020

General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood

1 reference

12 December 2020

Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes

1 reference

12 December 2020

Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy

1 reference

12 December 2020

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

1 reference

12 December 2020

New approaches to the study of the cellular biology of the cardiovascular system.

1 reference

12 December 2020

Mood changes during captopril therapy for hypertension. A double-blind pilot study.

1 reference

12 December 2020

Lowering of arterial blood pressure limits glomerular sclerosis in rats with renal ablation and in experimental diabetes

1 reference

12 December 2020

Pilot Study of the Effects of the Angiotensin-Converting Enzyme Inhibitor CI-906 on Patients with Essential Hypertension

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors. Properties and side effects

1 reference

12 December 2020

Recent developments in the design of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Effect of chronic nifedipine in patients inadequately controlled by a converting enzyme inhibitor and a diuretic

1 reference

12 December 2020

Antihypertensive drug treatment in elderly hypertensive subjects: evidence of protection

1 reference

12 December 2020

Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.

1 reference

12 December 2020

Captopril in the treatment of clinical hypertension and cardiac failure

1 reference

12 December 2020

Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan

1 reference

12 December 2020

Combined treatment of severe intractable hypertension with captopril and diuretic

1 reference

12 December 2020

Interaction of slow-channel calcium blocking drugs with sodium restriction, diuretics and angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

1 reference

12 December 2020

Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension

1 reference

12 December 2020

Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure

1 reference

12 December 2020

Tubular transport responses to angiotensin

1 reference

12 December 2020

Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects

1 reference

12 December 2020

Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension

1 reference

12 December 2020

10.2165/00003495-199040030-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1044564200

0 references

1 reference